|Bid||0.6920 x 1000|
|Ask||0.7188 x 2900|
|Day's range||0.6910 - 0.7202|
|52-week range||0.4200 - 2.7800|
|Beta (5Y monthly)||0.94|
|PE ratio (TTM)||0.68|
|Earnings date||11 Feb 2021 - 15 Feb 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||3.00|
The latest analyst coverage could presage a bad day for Acorda Therapeutics, Inc. (NASDAQ:ACOR), with the analysts...
Acorda (ACOR) delivered earnings and revenue surprises of 23.33% and 80.64%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Acorda Therapeutics, Inc. (NASDAQ:ACOR) today reported its financial results for the third quarter ended September 30, 2020.